Bristol-Myers Squibb Canada Co. et al. v. Novopharm Ltd. et al., (2005) 282 F.T.R. 255 (FC)
Linked as:
Extract
Bristol-Myers Squibb Canada Co. et al. v. Novopharm Ltd. et al., (2005) 282 F.T.R. 255 (FC)
No longer available (Autolink)
See the full content of this document
This document cites
- Janssen-Ortho Inc. et al. v. Novopharm Ltd. et al., (2004) 264 F.T.R. 202 (FC)
- Halford et al. v. Seed Hawk Inc. et al., (2002) 222 F.T.R. 232 (TD)
- Procter & Gamble Pharmaceuticals Canada Inc. et al. v. Canada (Minister of Health) et al., 2004 FC 204
- Pfizer Canada Inc. et al. v. Apotex Inc. et al., (2002) 225 F.T.R. 1 (TD)
- Whirlpool Corp. et al. v. Camco Inc. et al., (2000) 263 N.R. 88 (SCC)
